cancer. Rather, as we mentioned in the Discussion, it is to be used as hypothesis-generating fodder for a prospective randomized trial examining stenting with or without brachytherapy-an investigation that we are currently undertaking (search for NCT01366833 at http://clinicaltrials.gov/). We appreciate the comments and elegant statistical analysis by Dr. Cavallin and others, but we believe that they miss the forest for the trees. Our manuscript-being a retrospective review of our experience managing this complex patient population, captured in a prospective database-clearly has several statistical limitations common to studies of this type and is by no means a definitive comment on the treatment of patients with metastatic esophageal Curr Oncol, Vol. 19, pp. e502; doi: http://dx.doi.org/10.3747/co.19.1179 
